Please login to the form below

Not currently logged in
Email:
Password:

Fotivda

This page shows the latest Fotivda news and features for those working in and with pharma, biotech and healthcare.

Aveo’s tivozanib is knocked back by FDA once again

Aveo’s tivozanib is knocked back by FDA once again

EMA to approve the drug as Fotivda in Europe in 2017 based on the TIVO-1 data. ... Fast forward a few years , and Fotivda’s license in Europe is at risk of being  withdrawn, and the company’s attempt to file in the US based on TIVO-3

Latest news

More from news
Approximately 3 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...

Latest intelligence

WHITE PAPER: Why do men die younger?
It’s a commonly accepted fact that women outlive men. Wherever you live, there’s a good chance that men will die on average eight years earlier than women. Is this an...
3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...

Infographics